Pensionfund Dsm Netherlands Biogen Inc. Transaction History

Pensionfund Dsm Netherlands

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$193.77 - $244.14 $465,048 - $585,936	-2,400 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $2.72 Million - $3.54 Million	-9,600 Reduced 80.0%	2,400 $679,000
Q1 2021 Apr 01, 2021	BUY	$242.95 - $284.63 $194,360 - $227,704	800 Added 7.14%	12,000 $3.36 Million
Q2 2019 Jul 02, 2019	BUY	$219.29 - $241.72 $416,651 - $459,268	1,900 Added 20.43%	11,200 $2.62 Million
Q3 2018 Oct 01, 2018	SELL	$293.51 - $383.83 $587,020 - $767,660	-2,000 Reduced 17.7%	9,300 $3.29 Million
Q1 2018 Apr 03, 2018	SELL	$260.13 - $367.91 $1.09 Million - $1.55 Million	-4,200 Reduced 27.1%	11,300 $3.09 Million
Q3 2017 Oct 04, 2017	BUY	$281.15 - $329.69 $4.36 Million - $5.11 Million	15,500	15,500 $4.85 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pensionfund Dsm Netherlands, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Dsm Netherlands with notifications on news.